---
schema_version: "secwatch.filing_event.v1"
accession: "0001090872-25-000010"
form_type: "8-K"
ticker: "A"
cik: "0001090872"
company_name: "AGILENT TECHNOLOGIES, INC."
filed_at: "2025-03-03T23:59:59+00:00"
generated_at: "2026-05-25T16:51:57.482654+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "medium"
source: SEC EDGAR
---

# Agilent reorganizes segments into Life Sciences & Diagnostics Markets, Agilent CrossLab, Applied Markets

## Summary
- Former Diagnostics & Genomics merged with LC/MS platforms into Life Sciences and Diagnostics Markets segment.
- Chemistries, supplies, lab automation, software, informatics moved to Agilent CrossLab segment.
- GC/MS, spectroscopy, vacuum divisions form new Applied Markets segment.
- Recast of 2024 10-K Items 1, 2, 7, 8 reflects new segments; no change to audited financials.

## SEC filing metadata
- accession: 0001090872-25-000010
- form_type: 8-K
- ticker: A
- cik: 0001090872
- company_name: AGILENT TECHNOLOGIES, INC.
- filed_at: 2025-03-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: medium
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1090872/000109087225000010/0001090872-25-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1090872/000109087225000010/a-20250303_d2.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001090872-25-000010
- JSON: https://secwatch.observer/filing/0001090872-25-000010.json
- Plain text: https://secwatch.observer/filing/0001090872-25-000010.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.